» Articles » PMID: 25011992

Public Perceptions of Cancer: a Qualitative Study of the Balance of Positive and Negative Beliefs

Overview
Journal BMJ Open
Specialty General Medicine
Date 2014 Jul 12
PMID 25011992
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Cancer's insidious onset and potentially devastating outcomes have made it one of the most feared diseases of the 20th century. However, advances in early diagnosis and treatment mean that death rates are declining, and there are more than 30 million cancer survivors worldwide. This might be expected to result in more sanguine attitudes to the disease. The present study used a qualitative methodology to provide an in-depth exploration of attitudes to cancer and describes the balance of negative and positive perspectives.

Design: A qualitative study using semistructured interviews with thematic analysis.

Setting: A university in London, UK.

Participants: 30 participants (23-73 years), never themselves diagnosed with cancer.

Results: Accounts of cancer consistently incorporated negative and positive views. In almost all respondents, the first response identified fear, trauma or death. However, this was followed-sometimes within the same sentence-by acknowledgement that improvements in treatment mean that many patients can survive cancer and may even resume a normal life. Some respondents spontaneously reflected on the contradictions, describing their first response as a 'gut feeling' and the second as a more rational appraisal-albeit one they struggled to believe. Others switched perspective without apparent awareness.

Conclusions: People appear to be 'in two minds' about cancer. A rapid, intuitive sense of dread and imminent death coexists with a deliberative, rational recognition that cancer can be a manageable, or even curable, disease. Recognising cancer's public image could help in the design of effective cancer control messages.

Citing Articles

Extending the concept of total pain to cancer survivorship.

Krawczyk M, Solbraekke K, Thoresen L Front Sociol. 2025; 9:1387096.

PMID: 39949637 PMC: 11821597. DOI: 10.3389/fsoc.2024.1387096.


Migrant women's perception toward cervical and breast cancer screening in Türkiye: a qualitative analysis.

Altas Z, Sezerol M BMC Public Health. 2025; 25(1):190.

PMID: 39825324 PMC: 11740554. DOI: 10.1186/s12889-025-21425-z.


Understanding Cancer Treatment Decision Making Among Cancer Survivors: Weighing Cancer Recurrence Versus Cardiotoxicity.

Streck B, Vo J, Brandt C, Klein W, Han P, Ferrer R Psychooncology. 2025; 34(1):e70061.

PMID: 39822080 PMC: 11739822. DOI: 10.1002/pon.70061.


Facilitators and barriers to decision-making for hospital treatment among patients diagnosed with breast cancer in Dar es Salaam, Tanzania: A qualitative urban-based study.

Dominic P, Iseselo M, Athanas R PLOS Glob Public Health. 2024; 4(11):e0003366.

PMID: 39509439 PMC: 11542803. DOI: 10.1371/journal.pgph.0003366.


Recognizing and navigating barriers to hope in gastrointestinal cancer patients.

Venkataraman D, Rao D J Gastrointest Oncol. 2024; 15(3):1355-1357.

PMID: 38989430 PMC: 11231856. DOI: 10.21037/jgo-24-353.


References
1.
Beeken R, Simon A, Von Wagner C, Whitaker K, Wardle J . Cancer fatalism: deterring early presentation and increasing social inequalities?. Cancer Epidemiol Biomarkers Prev. 2011; 20(10):2127-31. PMC: 3189396. DOI: 10.1158/1055-9965.EPI-11-0437. View

2.
Kearney N, Miller M, Paul J, Smith K, Rice A . Oncology health care professionals' attitudes to cancer: a professional concern. Ann Oncol. 2002; 14(1):57-61. DOI: 10.1093/annonc/mdg018. View

3.
Dein S . Explanatory models of and attitudes towards cancer in different cultures. Lancet Oncol. 2004; 5(2):119-24. DOI: 10.1016/S1470-2045(04)01386-5. View

4.
Redmond K . Promoting better quality media coverage of cancer. Nat Clin Pract Oncol. 2007; 4(11):613. DOI: 10.1038/ncponc0977. View

5.
Miles A, Rainbow S, Von Wagner C . Cancer fatalism and poor self-rated health mediate the association between socioeconomic status and uptake of colorectal cancer screening in England. Cancer Epidemiol Biomarkers Prev. 2011; 20(10):2132-40. PMC: 3199581. DOI: 10.1158/1055-9965.EPI-11-0453. View